Assi T - Search Results

1

The Forgotten Complication of Recurrent Nephrolithiasis: "Squamous Cell Carcinoma of the Renal Pelvis"-A Case and Review of the Literature.

Assi T, El Rassy E, Naderi S, Moussa T, Moukarzel M, Kattan J. Assi T, et al. Case Rep Urol. 2015;2015:298317. doi: 10.1155/2015/298317. Epub 2015 Oct 22. Case Rep Urol. 2015. PMID: 26579326 Free PMC article.

2

Solitary Laryngeal Metastasis from Transitional Cell Carcinoma of the Kidney: Clinical Case and Review of the Literature.

Assi T, El Rassy E, Haddad A, Kattan J. Assi T, et al. Case Rep Otolaryngol. 2015;2015:595283. doi: 10.1155/2015/595283. Epub 2015 Jul 6. Case Rep Otolaryngol. 2015. PMID: 26236525 Free PMC article.

3

Isolated Celiac and Splenic Artery Dissection: A Case Report and Review of the Literature.

Moussa T, Nawfal G, Assi T, El Rassy E, Massoud E, Daou I. Moussa T, et al. Among authors: assi t. Case Rep Vasc Med. 2015;2015:194079. doi: 10.1155/2015/194079. Epub 2015 Dec 24. Case Rep Vasc Med. 2015. PMID: 26819797 Free PMC article.

4

Overview on the role of preoperative therapy in the management of kidney cancer.

Assi T, El Rassy E, Farhat F, Kattan J. Assi T, et al. Clin Transl Oncol. 2020 Jan;22(1):11-20. doi: 10.1007/s12094-019-02136-5. Epub 2019 May 29. Clin Transl Oncol. 2020. PMID: 31144210 Review.

5

Treatment of cancer patients in their last month of life: aimless chemotherapy.

Assi T, El Rassy E, Tabchi S, Ibrahim T, Moussa T, Chebib R, El Karak F, Farhat F, Chahine G, Nasr F, Ghosn M, Kattan J. Assi T, et al. Support Care Cancer. 2016 Apr;24(4):1603-8. doi: 10.1007/s00520-015-2959-3. Epub 2015 Sep 21. Support Care Cancer. 2016. PMID: 26391890

6

Pancreatic small cell cancer.

El Rassy E, Tabchi S, Kourie HR, Assi T, Chebib R, Farhat F, Kattan J. El Rassy E, et al. Among authors: assi t. Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):276-280. doi: 10.1016/j.clinre.2015.09.010. Epub 2015 Nov 11. Clin Res Hepatol Gastroenterol. 2016. PMID: 26566245 Review.

7

Is minimal residual disease a convincing tool to determine the treatment duration of immune checkpoint inhibitors?

El Rassy E, Assi T, Kattan J. El Rassy E, et al. Among authors: assi t. Future Oncol. 2017 Feb;13(5):381-383. doi: 10.2217/fon-2016-0462. Epub 2016 Nov 25. Future Oncol. 2017. PMID: 27884060 No abstract available.

8

Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.

El Rassy E, Assi T, Bakouny Z, El Karak F, Pavlidis N, Ghosn M. El Rassy E, et al. Among authors: assi t. Future Oncol. 2019 Mar;15(8):909-923. doi: 10.2217/fon-2018-0663. Epub 2019 Jan 23. Future Oncol. 2019. PMID: 30669875 Review.

9

Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder.

El Rassy E, Assi T, Bakouny Z, Pavlidis N, Kattan J. El Rassy E, et al. Among authors: assi t. Clin Transl Oncol. 2019 Mar;21(3):280-288. doi: 10.1007/s12094-018-1935-z. Epub 2018 Sep 4. Clin Transl Oncol. 2019. PMID: 30182210 Review.

10

Immune checkpoints inhibitors in metastatic squamous cell carcinoma of the vulva.

Assi T, Kattan J, Othman A, Farhat F. Assi T, et al. Future Oncol. 2021 Aug;17(24):3133-3135. doi: 10.2217/fon-2021-0610. Epub 2021 Jul 2. Future Oncol. 2021. PMID: 34213372 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters